Literature DB >> 1672408

Prophylactic oral fluconazole and candida fungaemia.

C P Case, A P MacGowan, N M Brown, D S Reeves, P Whitehead, D Felmingham.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1672408     DOI： 10.1016/0140-6736(91)91406-k

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

Review 1.  Resistance of Candida species to fluconazole.

Authors:  J H Rex; M G Rinaldi; M A Pfaller
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

2.  Efficacy of D0870 treatment of experimental Candida vaginitis.

Authors:  P L Fidel; J L Cutright; J D Sobel
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

3.  Differential humoral response against alpha- and beta-linked mannose residues associated with tissue invasion by Candida albicans.

Authors:  T Jouault; C Delaunoy; B Sendid; F Ajana; D Poulain
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

Review 4.  Antifungal susceptibility testing.

Authors:  J H Rex; M A Pfaller; M G Rinaldi; A Polak; J N Galgiani
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

5.  Rationale for selective use of anaerobic blood cultures.

Authors:  A J Morris; M L Wilson; S Mirrett; L B Reller
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

Review 6.  Susceptibility testing of fungi: current status of the standardization process.

Authors:  J N Galgiani
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

7.  In vitro studies of a new antifungal triazole, D0870, against Candida albicans, Cryptococcus neoformans, and other pathogenic yeasts.

Authors:  T Peng; J N Galgiani
Journal:  Antimicrob Agents Chemother       Date:  1993-10       Impact factor: 5.191

8.  Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1.

Authors:  M L Cameron; W A Schell; S Bruch; J A Bartlett; H A Waskin; J R Perfect
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

9.  Efficacy of some natural compounds as antifungal agents.

Authors:  Sudha Vengurlekar; Rajesh Sharma; Piyush Trivedi
Journal:  Pharmacogn Rev       Date:  2012-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.